Literature DB >> 11408613

Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells.

D Oliver1, J Ludwig, E Reisinger, W Zoellner, J P Ruppersberg, B Fakler.   

Abstract

Memantine is a blocker of Ca(2+)-permeable glutamate and nicotinic acetylcholine receptors (nAChR). We investigated the action of memantine on cholinergic synaptic transmission at cochlear outer hair cells (OHCs). At this inhibitory synapse, hyperpolarization of the postsynaptic cell results from opening of SK-type Ca(2+)-activated K(+) channels via a highly Ca(2+)-permeable nAChR containing the alpha 9 subunit. We show that inhibitory postsynaptic currents recorded from OHCs were reversibly blocked by memantine with an IC(50) value of 16 microM. RT-PCR revealed that a newly cloned nAChR subunit, alpha 10, is expressed in OHCs. In contrast to homomeric expression, coexpression of alpha 9 and alpha 10 subunits in Xenopus laevis oocytes resulted in robust acetylcholine-induced currents, indicating that the OHC nAChR may be an alpha 9/alpha 10 heteromer. Accordingly, nAChR currents evoked by application of the ligand to OHCs and currents through alpha 9/alpha 10 were blocked by memantine with a similar IC(50) value of about 1 microM. Memantine block of alpha 9/alpha 10 was moderately voltage dependent. The lower efficacy of memantine for inhibition of inhibitory postsynaptic currents (IPSCs) most probably results from a blocking rate that is slow with respect to the short open time of the receptor channels during an IPSC. Thus, synaptic transmission in OHCs is inhibited by memantine block of Ca(2+) influx through nAChRs. Importantly, prolonged receptor activation and consequently massive Ca(2+) influx, as might occur under pathological conditions, is blocked at low micromolar concentrations, whereas the fast IPSCs initiated by short receptor activation are only blocked at concentrations above 10 microM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408613     DOI: 10.1124/mol.60.1.183

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  14 in total

1.  Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.

Authors:  Shawn E Kotermanski; Jon W Johnson
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

2.  PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLD.

Authors:  R Salvi; E Lobarinas; W Sun
Journal:  Drugs Future       Date:  2009       Impact factor: 0.148

3.  Linopirdine blocks alpha9alpha10-containing nicotinic cholinergic receptors of cochlear hair cells.

Authors:  María E Gomez-Casati; Eleonora Katz; Elisabeth Glowatzki; María I Lioudyno; Paul Fuchs; A Belén Elgoyhen
Journal:  J Assoc Res Otolaryngol       Date:  2004-06-24

4.  Neuropharmacology of vestibular system disorders.

Authors:  Enrique Soto; Rosario Vega
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

5.  Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.

Authors:  Michele Fornaro; Matteo Martino
Journal:  Neuropsychiatr Dis Treat       Date:  2010-06-24       Impact factor: 2.570

Review 6.  Emerging pharmacotherapy of tinnitus.

Authors:  Berthold Langguth; Richard Salvi; Ana Belén Elgoyhen
Journal:  Expert Opin Emerg Drugs       Date:  2009-12       Impact factor: 4.191

7.  Effects of extracochlear gacyclidine perfusion on tinnitus in humans: a case series.

Authors:  Gentiana Ioana Wenzel; Athanasia Warnecke; Timo Stöver; Thomas Lenarz
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-22       Impact factor: 2.503

8.  Memantine's action against aminoglycoside-induced ototoxicity.

Authors:  Pavlos Pavlidis; Jan Maurer; Eirini Apostolidou; Georgios Kekes; Dimitrios Kouvelas
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-06       Impact factor: 2.503

9.  Traumatic noise activates Rho-family GTPases through transient cellular energy depletion.

Authors:  Fu-Quan Chen; Hong-Wei Zheng; Kayla Hill; Su-Hua Sha
Journal:  J Neurosci       Date:  2012-09-05       Impact factor: 6.167

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.